Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Healthtrust
Farmers Insurance
Federal Trade Commission
Fish and Richardson
Mallinckrodt
Citi
Covington

Generated: May 25, 2018

DrugPatentWatch Database Preview

Bepotastine besilate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for bepotastine besilate and what is the scope of bepotastine besilate freedom to operate?

Bepotastine besilate
is the generic ingredient in one branded drug marketed by Bausch And Lomb Inc and is included in one NDA. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Bepotastine besilate has forty-five patent family members in sixteen countries.

There are seven drug master file entries for bepotastine besilate. Two suppliers are listed for this compound.
Pharmacology for bepotastine besilate
Synonyms for bepotastine besilate
(+)-(S)-4-(4-((4-Chlorophenyl)(2-pyridyl)methoxy)piperidino)butyric acid monobenzenesulfonate
(+)-(S)-4-[4-[1-(4-Chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid benzenesulfonate
(S)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1)
(S)-4-[4-(4-Chlorophenyl-2-pyridylmethoxy)piperidinyl]butyric Acid Benzenesulfonate
(s)-4-[4-[(4-chlorophenyl)(2-pyridyl)-methoxy]piperidino]butanoic acid monobenzenesulfonic acid salt
(s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic acid monobenzenesulfonic acid salt
1-Piperidinebutanoic acid, 4-((4-chlorophenyl)-2-pyridinylmethoxy)- (S)-, monobenzenesulfonate
1-piperidinebutanoic acid, 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-, (s)-, monobenzenesulfonate
1-piperidinebutanoic acid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-, monobenzenesulfonate
190786-44-8
4-((4-Chlorophenyl)-2-pyridinylmethoxy)- (S)-1-piperidinebutanoic acid monobenzenesulfonate
4-[(S)-(4-Chlorophenyl)-2-pyridinylmethoxy]-1-piperidinebutanoic Acid Benzenesulfonate
4-[4-[(r)-(4-chlorophenyl)-pyridin-2-yl-methoxy]-1-piperidyl]butanoic acid
4-{4-[(s)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid benzenesulfonate
6W18MO1QR3
786B448
ABP001064
AC-24015
AC1L4UXJ
AC1Q6WSY
AK322015
AKOS025401655
AN-5247
API0001668
AS-17863
BC214879
benzenesulfonic acid; 4-[4-[(S)-(4-chlorophenyl)-(2-pyridyl)methoxy]-1-piperidyl]butanoic acid
benzenesulfonic acid; 4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
benzenesulfonic acid;4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
Bepomax
Bepotastine (Beslilate)
Bepotastine benzenesulfonate
Bepotastine Benzenesulfonate Salt
Bepotastine besilate (JP17)
Bepotastine Besitate
Bepotastine Beslilat
Bepotastine besylate
Bepotastine besylate (USAN)
Bepotastine besylate [USAN]
Bepreve
Bepreve (TN)
Betotastine besilate
C27H31ClN2O6S
CB0259
CHEBI:31281
CHEMBL1201759
CS-0383
CTK4E0497
D01654
DTXSID80172577
FT-0655883
HY-A0015
J-012325
KS-00000FR0
LS-114358
MFCD01938491
MolPort-005-938-034
PubChem19122
s3037
SC-47417
SCHEMBL1287638
Talion
Talion (TN)
TAU-284
tau284
UDGHXQPQKQPSBB-BOXHHOBZSA-N
UNII-6W18MO1QR3
V2224
W-5279

US Patents and Regulatory Information for bepotastine besilate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb Inc BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288-001 Sep 8, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Bausch And Lomb Inc BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288-001 Sep 8, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Bausch And Lomb Inc BEPREVE bepotastine besilate SOLUTION/DROPS;OPHTHALMIC 022288-001 Sep 8, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for bepotastine besilate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,307,052 Acid-addition salts of optically active piperidine compound and process for producing the same ➤ Try a Free Trial
8,883,825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations ➤ Try a Free Trial
7,282,589 Acid addition salt of optically active piperidine compound and process for preparing the same ➤ Try a Free Trial
9,849,121 Aqueous liquid preparations and light-stabilized aqueous liquid preparations ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Teva
US Department of Justice
Fuji
Covington
Julphar
McKinsey
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.